Literature DB >> 7560970

Molecular typing of Aspergillus species.

M Birch1, M J Anderson, D W Denning.   

Abstract

In the last four years, several molecular typing methods have been applied to various Aspergillus species, primarily A. fumigatus and A. niger. Many 'clones' or DNA types exist in the environment and in patients. The most discriminatory methods appear to be restriction fragment length polymorphism analysis with or without specific probes and random amplification of polymorphic DNA analysis. Insufficient work on interlaboratory reproducibility has been done. Most patients are infected by single DNA types, although occasionally multiple isolates are detected. Little work has been done with regard to detailed hospital epidemiology using molecular typing methods.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7560970     DOI: 10.1016/0195-6701(95)90037-3

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  4 in total

1.  Genetic polymorphism of Aspergillus fumigatus in clinical samples from patients with invasive aspergillosis: investigation using multiple typing methods.

Authors:  S Bertout; F Renaud; R Barton; F Symoens; J Burnod; M A Piens; B Lebeau; M A Viviani; F Chapuis; J M Bastide; R Grillot; M Mallié
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

2.  RAPD typing of Aspergillus chevalieri, Aspergillus nidulans, Aspergillus tetrazonus (quadrilineatus) and their teleomorphs using 5'-d[AACGCGCAAC]-3' and 5'-d[CCCGTCAGCA]-3' primers.

Authors:  Akram A Abu Seadah; Mohey Eldin El Shikh
Journal:  Mol Biol Rep       Date:  2007-02-01       Impact factor: 2.316

3.  Differentiation of Aspergillus niger by random amplification of polymorphic DNA.

Authors:  Kawther F Abed
Journal:  J Ind Microbiol Biotechnol       Date:  2008-06-11       Impact factor: 3.346

4.  Madurella mycetomatis strains from mycetoma lesions in Sudanese patients are clonal.

Authors:  Abdalla Ahmed; Wendy van de Sande; Henri Verbrugh; Ahmed Fahal; Alex van Belkum
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.